Progyny, Inc.
Progyny, Inc. (PGNY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PGNY · as of Jun 8, 2026
Key Statistics
Explore Progyny, Inc. Data
pgny stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 20 · Buy rate: 75.0%
The PGNY analyst consensus is Buy, based on ratings from 20 Wall Street analysts over the past 3 months. The average 12-month price target is $30.33, representing +16.41% upside from the current price of $26.05.
Competitors & Peers
pgny competitorsPGNY
ALVO
GDRX
OMCL
OMDA
PHRStock Performance
Full HistoryAbout Progyny, Inc.
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United Stat…
what is progyny, inc. · pgny stock overview · progyny, inc. company profile · who is progyny, inc. ceo · pgny NASDAQ · progyny, inc. headquarters · progyny, inc. business segments
About Stock Overview & Key Data
Progyny, Inc. (PGNY) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NASDAQ since Oct 25, 2019. As of the latest trading session, PGNY stock price is $26.05, with a market capitalization of $2.0B. The stock has returned +18.12% over the past 12 months and +1.05% year-to-date.
According to 20 Wall Street analysts, the consensus rating for Progyny, Inc. stock is Buy, with an average 12-month price target of $30.33. In fiscal year 2025, Progyny, Inc. reported revenue of $1.3B and net income of $58.5M. For detailed data — including Progyny, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Progyny, Inc. (PGNY) stock price is $26.05. The stock is traded on NASDAQ under the ticker symbol PGNY. The 52-week range is $16.10 – $28.75.